Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis
Arthritis & Rheumatology · 2025
DOI: 10.1002/art.43265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Burcu Aydemir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents, Pain Threshold. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Objective
Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease‐modifying antirheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity.
Methods
We included 182 participants with active RA initiating/switching DMARD therapy who were observed for 12 weeks. To assess pain sensitization, participants underwent quantitative sensory testing (QST), including pressure pain thresholds (PPTs) at multiple anatomic sites, temporal summation (TS) at the wrist and forearm, and conditioned pain modulation (CPM). RA disease activity was measured using the Disease Activity Score 28 with C‐reactive protein (DAS28‐CRP) and its components. Mean changes in QST measures were examined from baseline to 12 weeks, and associations between QST and disease activity measures were explored using Pearson correlation coefficients and adjusted linear regression analyses.
Results
PPTs significantly increased (improved) at multiple anatomic sites following 12 weeks of DMARD therapy. No significant changes were observed in TS or CPM. Increased PPTs at multiple anatomic sites were associated with reductions in DAS28‐CRP, swollen joint count, tender joint count, and improvements in patient global assessment. No significant associations were observed between TS, CPM, and disease activity.
Conclusion
Pain sensitivity improved after 12 weeks of DMARD therapy. These improvements were associated with reductions in disease activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Northwestern University Feinberg School of Medicine, Chicago, Illinois.
- Western Michigan University School of Medicine, Kalamazoo.
- Massachusetts General Brigham, Boston.
- University of Michigan Medical School, Ann Arbor.
- Massachusetts General Hospital, Boston.
- Johns Hopkins University School of Medicine, Baltimore, Maryland.
ORCID-Profile: Burcu Aydemir, Andrew C Heisler, Jing Song, Alyssa Wohlfahrt, Daniel J Clauw, Marcy B Bolster, Clifton O Bingham, Tuhina Neogi, Yvonne C Lee
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Aydemir, B., Heisler, A. C., Muhammad, L. N., Song, J., Wohlfahrt, A., Clauw, D. J., Marder, W., Bolster, M. B., Bingham, C. O., Neogi, T., & Lee, Y. C. (2025). Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43265
Vancouver
Aydemir B, Heisler AC, Muhammad LN, Song J, Wohlfahrt A, Clauw DJ, et al. Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43265
BibTeX
@article{Aydemir2025,
author = {Aydemir, Burcu and Heisler, Andrew C and Muhammad, Lutfiyya N and Song, Jing and Wohlfahrt, Alyssa and Clauw, Daniel J and Marder, Wendy and Bolster, Marcy B and Bingham, Clifton O and Neogi, Tuhina and Lee, Yvonne C},
title = {Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis},
journal = {Arthritis & Rheumatology},
year = {2025},
doi = {10.1002/art.43265}
}
EUVIMED